Encapsulation of Insulin Producing Cells for Diabetes Treatment Using Alginate and Cellulose Sulphate as Bioencapsulation Polymers

作者: Walter H Gunzburg , John A Dangerfield , Eva Maria Brandtner , Brian Salmons

DOI:

关键词:

摘要: It has long been the holy grail of cell encapsulation to treat diabetes with insulin producing cells that are shielded from rejection or clearance by host immune system. Indeed, idea around for more than 50 years first demonstration in an animal model being published 1980 and patient treated reported 1994. In meantime, clinical experience accrued use encapsulated treatment human diabetes. Most these studies have focused on alginate as material although some promising data obtained is reviewed this article, it still far a product can be routinely applied. Cellulose sulphate excellent properties making ideal shown safe 27 patients. Moreover, showing safety efficacy rat supporting cellulose might choice application. DOI:10.14437/2377-7206-1-102 Review Brian Salmons,

参考文章(34)
Brian Salmons, Walter H. Gunzburg, Therapeutic application of cell microencapsulation in cancer. Advances in Experimental Medicine and Biology. ,vol. 670, pp. 92- 103 ,(2010) , 10.1007/978-1-4419-5786-3_9
Walter H Gunzburg, Wolfgang Wagenknecht, Bert Volkert, John A Dangerfield, Eva M Brandtner, Steffen Fischer, Kay Hettrich, Brian Salmons, Encapsulated cells to focus the metabolic activation of anticancer drugs. Current Opinion in Molecular Therapeutics. ,vol. 12, pp. 450- ,(2010)
Ram I. Mahato, Hao Wu, Mesenchymal stem cell-based therapy for type 1 diabetes. Discovery Medicine. ,vol. 17, pp. 139- 143 ,(2014)
David KC Cooper, Rita Bottino, Pierre Gianello, Melanie Graham, Wayne J Hawthorne, Allan D Kirk, Olle Korsgren, Chung‐Gyu Park, Collin Weber, None, First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 4: pre-clinical efficacy and complication data required to justify a clinical trial. Xenotransplantation. ,vol. 23, pp. 46- 52 ,(2016) , 10.1111/XEN.12226
Walter H. Gunzburg, Randolph Corteling, Jean-Pierre Abastado, John A. Dangerfield, Eva M. Brandtner, John Sinden, Brian Salmons, The Diversity of Uses for Cellulose Sulphate Encapsulation ,(2013)
Vijayaganapathy Vaithilingam, Bernard E. Tuch, Islet transplantation and encapsulation: an update on recent developments. The review of diabetic studies : RDS. ,vol. 8, pp. 51- 67 ,(2011) , 10.1900/RDS.2011.8.51
V. Stadlbauer, P. B. Stiegler, S. Schaffellner, O. Hauser, G. Halwachs, F. Iberer, K. H. Tscheliessnigg, C. Lackner, Morphological and functional characterization of a pancreatic beta-cell line microencapsulated in sodium cellulose sulfate/poly(diallyldimethylammonium chloride). Xenotransplantation. ,vol. 13, pp. 337- 344 ,(2006) , 10.1111/J.1399-3089.2006.00315.X
Robert B Elliott, Livia Escobar, Paul LJ Tan, Maria Muzina, Sahar Zwain, Christina Buchanan, None, Live encapsulated porcine islets from a type 1 diabetic patient 9.5 yr after xenotransplantation Xenotransplantation. ,vol. 14, pp. 157- 161 ,(2007) , 10.1111/J.1399-3089.2007.00384.X
Argia Acarregui, Ainhoa Murua, José L. Pedraz, Gorka Orive, Rosa M. Hernández, A perspective on bioactive cell microencapsulation. BioDrugs. ,vol. 26, pp. 283- 301 ,(2012) , 10.1007/BF03261887
Paul de Vos, Milica Spasojevic, Bart J. de Haan, Marijke M. Faas, The association between in vivo physicochemical changes and inflammatory responses against alginate based microcapsules. Biomaterials. ,vol. 33, pp. 5552- 5559 ,(2012) , 10.1016/J.BIOMATERIALS.2012.04.039